Myomo Reports Second Quarter 2026 Financial and Operating Results
Myomo reported Q2 2026 revenue of $11.7 million, up 21% year-over-year, driven by higher volume and pricing with 211 MyoPro units recognized. Gross margin expanded 940 basis points to 72.1% while operating expenses remained flat, narrowing the operating loss to $2.3 million and improving Adjusted EBITDA by 79%.
Key figures
- Revenue
- 11700000
- Guidance
- FY26 revenue $45-47 million, Q3 revenue $11.5-12.0 million
- Revenue Yoy
- 21%
- Asp
- 55500
- Cash
- 13500000
- Units sold
- 211
- Gross margin
- 72.1%
- Operating loss
- 2300000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.